Our data emphasized the pro-apoptotic and pro-inflammatory potential of drugs targeting the EGFR-ERK axis in the epidermis, with implications for their toxicity but also for activation of the anti-cancer defense in the skin. This evidence concerns the gene MAPK1 and cancer.